Cocrystal Pharma Inc.

09/26/2024 | Press release | Distributed by Public on 09/26/2024 06:01

Cocrystal Pharma Advances Oral Pan Viral Protease Inhibitor CDI 988 into Phase 1 Multiple Ascending Dose Cohorts